Early Detection of Cancer- Cancer research UK Flashcards

1
Q

What is early detection and diagnosis research?

A

Research which seeks to enable the detection of consequential cancer, or pre- cancerous states, at the earliest possible time point at which an intervention might be made, seeks to understand the role of patients, healthcare professionals and healthcare providers in cancer diagnosis, and to develop diagnostics in a population or clinical context.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does early detection and diagnosis research include?

A
  • Discovery and validation of marker signatures which detect (and prognose/stratify)
  • Developing technologies which will enable detection of robust, informative signals
  • Translational and clinical research; proof of concept for new ED&D approaches
  • Utility and health economic impact
  • Influence patient/clinician behaviour
  • Policy/health system delivery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

To detect cancers at the earliest possible stage, we need to find what?

A

A small number of cancer cells amongst trillions of healthy cells. Ideally, we would want to know where the cancer is and if the cancer will be consequential or benign.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the considerations for early detection tests?

A
  • Who is the target? (e.g. monitoring high risk individuals, screening the general population)
  • What is the sensitivity? - A sensitive test picks out cancer when it’s there so fewer cancers are missed (false negatives)
  • What is the specificity? - A specific test doesn’t pick up something else and say it’s cancer by mistake (false positives)
  • Where would the test be done (e.g. home, GP’s office, hospital)?
  • What is the cost of the test and its implementation?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What can early detection tests measure?

A
1. Blood tests
• CTCs
• ctDNA
• Genomic/methylation changes
• Exosomes
• Platelets
• Proteins
  1. Faecal tests
    • Blood
    • Volatile organic compounds
  2. Urine tests
    • DNA
    • Proteins

Other measurement modalities include breath and salvia. Cancer diagnosis may also
require imaging and would be confirmed with biopsies and pathology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Earlier detection also raises what concern?

A

Over diagnosis and over treatment.

Want to identify abnormal cells that will lead to cancer, not cells that are very slow or non progressive to the extent that they may lead to cancer but the cancer will definetely not be the cause of death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are challenges to the early detection field?

A

Bio and tech complexity

Fragmented expertise

Lack of visibility and identity

Poor industry and engagement

Lack of knowledge and exchange

Lack of scale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the challenges to the early detection of Colorectal cancer?

A
  • Screening uptake not high, vague early symptoms often not reported to GP
  • Some pre-cancerous growths (polyps) are difficult to detect through colonoscopy
  • Lack understanding of links to inherited conditions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the opportunities for the early detection of Colorectal cancer?

A
  • Low-cost, accessible alternative to FOBT/FIT and/or colonoscopy to improve screening uptake and diagnosis
  • Mechanism to enhance sessile polyp visibility during colonoscopy
  • Improved understanding of genetics of inherited predisposition, to identify at-risk families for screening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What screening methods are used for Colorectal cancer?

A

Faecal Occult Blood Test (FOBT) and now Faecal Immunochemical Test (FIT) every 2 years, age 60-74

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is used for the initial detection of Colorectal cancer?

A

Symptomatic FIT, Colonoscopy, CT Scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the challenges for the early detection of pancreatic cancer?

A

• Lack of symptoms leads to late presentation

• Poor vasculature of tumours reduces take-up of
imaging contrast media

• Two types of pre-cancer lesion – not all
develop into cancer- Which will become malignant? And when?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the opportunities for the early detection of pancreatic cancer?

A
  • Novel detection methods needed for asymptomatic cancer screening
  • Method to enable risk-stratification of cystic pre-cursor lesions (preferably non-invasive)
  • Approach for visualising microscopic lesions missed by CT scans
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is used to screen for pancreatic cancer?

A

Screening: No UK-wide programme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is used for the initial detection of pancreatic cancer?

A

CT scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the challenges for the early detection of brain cancer?

A
  • Symptoms are non-specific and vary depending on tumour location
  • Patients referred late, often after multiple visits to primary care
  • Most patients transferred from Stroke units or A&E after imaging reveals lesion
17
Q

What are the opportunities for the early detection of brain cancer?

A
  • Novel detection methods needed for screening and detection
  • Tool to assist with diagnosis in primary care and facilitate earlier referral by recognising symptoms and additional factors (eg. BRAcED, Headache PLUS)
  • Lower cost assay for MGMT to reduce delay in diagnosis and stratification
18
Q

How is brain cancer screened for?

A

No UK-wide programme

19
Q

What is used for the initial detection of brain cancer?

A

MRI scan, CT scan

20
Q

What are the challenges to the early detection of Oesophageal cancer?

A
  • Symptoms present slowly – patients tend to present at late stage
  • Heartburn is primary symptom – easy to dismiss and medicate
  • Early stages of adenocarcinoma (AC) and squamous cell carcinoma (SCC) can be invisible to eye and missed during endoscopy
  • No low-cost, simple test on market to enable mass screening
21
Q

What are the opportunities for the early detection of Oesophageal cancer?

A

• Develop an accurate, affordable ‘non-invasive’ test eg. (Breathalyser) to enable screening of large population
• Biomarkers to identify high-risk patients with Barrett’s
Oesophagus
• Novel methods to detect ‘invisible’ early cancerous
changes during endoscopy

22
Q

What is used to screen Oesophageal cancer?

A

No UK-wide programme

23
Q

What is used for the initial detection of Oesophageal cancer?

A

Endoscopy

Barium Swallow

24
Q

What are the emerging platform technologies for early detection across cancer sites?

A

Owlstone Medical:

  • Breath Biopsy device to detect VOCs in exhaled breath
  • 1500 participants on 2 year trial at Addenbrooke’s Hospital
  • Initially testing for early markers of oesophageal and stomach cancers

Grail:
Developing blood test to detect cancers early through 3 large-scale studies, launching NHS trial
• SUMMIT study to recruit 50,000 healthy participants
• Testing for tumour-derived DNA and RNA fragments in bloodstream as early marker of cancer

CancerSeek:
• Blood test that looks for mutations in 16 genes and 8 proteins associated with cancer
• Identified 70% of cancers in 1000 patients
• Will now look to evaluate and validate in large cohorts including healthy individuals

25
Q

How does cancer research UK use a multifaceted approach?

A
  1. Community building, consultations and networking
    - CRUK-Canary-OHSU Early Detection of Cancer Conference
    - A Road Map for EDx

-EDx Sandpit
Workshops

  1. Funding Research

EDx Project, Programme and
Primer Awards

Grand Challenge

  1. Investing in capabilities and infrastructure
- Alliance for Cancer
Early Detection (ACED)
  • 1 million person cohort from UK general population
  • Industry Engagement
26
Q

What are the research investments of cancer research UK?

A

Early detection and research

Basic understanding of cancer

Therapeutic innovation

Precision medicine

Cancer prevention

Cancers of substantial unmet need

27
Q

Why is early detection and diagnosis a CRUK priority?

A

Early detection is crucial for achieving 3 in 4 people surviving cancer

Most existing therapies work better when used earlier in disease course

Survival rates for many cancers improve dramatically
when disease is detected
earlier

Understanding the biology of early cancer (and pre-cancer) may also underpin target ID, precision medicine and prevention